» Articles » PMID: 29227460

Neuropathic-Like Ocular Pain and Nonocular Comorbidities Correlate With Dry Eye Symptoms

Overview
Specialty Ophthalmology
Date 2017 Dec 12
PMID 29227460
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the association between dry eye (DE) symptoms and neuropathic-like ocular pain (NOP) features, chronic pain conditions, depression, and anxiety in patients presenting for routine ophthalmic examinations.

Methods: Two hundred thirty-three consecutive patients ≥18 years of age presenting to a comprehensive eye clinic between January and August 2016 were included in this study. Information on demographics, chronic pain conditions, medication use, DE symptoms (dry eye questionnaire, DEQ5), NOP complaints (burning; wind, light, and temperature sensitivity), depression, and anxiety indices (patient health questionnaire 9, PHQ-9 and symptom checklist 90-revised, SCL-90-R) were collected for each individual. Pearson correlation was used to evaluate strengths of association. Logistic regression analysis examined risk factors for any (DEQ5≥6) and severe (DEQ5≥12) DE symptoms.

Results: The mean age of the population was 46.3 years (±13.0); 67.8% (n=158) were female. Per the DEQ5, 40.3% (n=94) had mild or greater DE symptoms and 12% (n=24) had severe symptoms. Severity of DE symptoms correlated with NOP complaints: burning (Pearson r=0.37, P<0.001); sensitivity to wind (r=0.37, P<0.001), sensitivity to light (r=0.34, P<0.001), and sensitivity to temperature (r=0.30, P<0.001). Sex, race, and ethnicity were not significant risk factors for DE symptoms. Risk factors for mild or greater DE symptoms included a greater number of chronic nonocular pain conditions (odds ratio [OR]=1.38, P<0.001), arthritic pain (OR=6.34, P<0.001), back pain (OR=2.47, P=0.004), headaches (OR=2.14, P=0.02), depression (OR=1.17, P<0.001), and anxiety (OR=1.13, P=0.02).

Conclusion: Dry eye severity positively associated with NOP complaints, comorbid chronic pain conditions, and symptoms of depression and anxiety.

Citing Articles

Validation of the Ocular Pain Assessment Survey Instrument With Rasch Analysis.

Ng D, Wang X, Liu C, Yu M, Yu Lee I, Wong J Transl Vis Sci Technol. 2025; 14(2):20.

PMID: 39964334 PMC: 11838117. DOI: 10.1167/tvst.14.2.20.


Influencing factors of ocular pain in dry eye disease patients at high altitude.

Zhang P, Jiang W, Wu Y, Dai H, Wang D, Bao Y Int J Ophthalmol. 2024; 17(12):2214-2220.

PMID: 39697888 PMC: 11589435. DOI: 10.18240/ijo.2024.12.08.


Corneal neuropathic pain: a review to inform clinical practice.

Watson S, Le D Eye (Lond). 2024; 38(12):2350-2358.

PMID: 38627548 PMC: 11306374. DOI: 10.1038/s41433-024-03060-x.


Genome Wide Association Study of Neuropathic Ocular Pain.

Huang J, Rodriguez D, Slifer S, Martin E, Levitt R, Galor A Ophthalmol Sci. 2023; 4(2):100384.

PMID: 37868788 PMC: 10587615. DOI: 10.1016/j.xops.2023.100384.


Association of Dry Eye Symptoms and Signs in Patients with Dry Eye Disease.

Tawfik A, Pistilli M, Maguire M, Chen Y, Yu Y, Greiner J Ophthalmic Epidemiol. 2023; 31(3):274-282.

PMID: 37592829 PMC: 10873469. DOI: 10.1080/09286586.2023.2248629.


References
1.
Kroenke K, Spitzer R, Williams J . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606-13. PMC: 1495268. DOI: 10.1046/j.1525-1497.2001.016009606.x. View

2.
Rosenthal P, Borsook D . Ocular neuropathic pain. Br J Ophthalmol. 2015; 100(1):128-34. PMC: 4717373. DOI: 10.1136/bjophthalmol-2014-306280. View

3.
Satitpitakul V, Kheirkhah A, Crnej A, Hamrah P, Dana R . Determinants of Ocular Pain Severity in Patients With Dry Eye Disease. Am J Ophthalmol. 2017; 179:198-204. DOI: 10.1016/j.ajo.2017.05.009. View

4.
Woolf C . Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983; 306(5944):686-8. DOI: 10.1038/306686a0. View

5.
Digre K, Brennan K . Shedding light on photophobia. J Neuroophthalmol. 2012; 32(1):68-81. PMC: 3485070. DOI: 10.1097/WNO.0b013e3182474548. View